HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mariama C Maiga Selected Research

Phosphodiesterase Inhibitors

12/2015Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.
8/2013Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mariama C Maiga Research Topics

Disease

6Tuberculosis (Tuberculoses)
12/2015 - 08/2013
1Infection
08/2015
1Granuloma
09/2013

Drug/Important Bio-Agent (IBA)

2Phosphodiesterase InhibitorsIBA
12/2015 - 08/2013
1RoflumilastIBA
12/2015
1Phosphotransferases (Kinase)IBA
08/2015
1CytokinesIBA
08/2015
1LactamsIBA
01/2014
1carbon monoxide dehydrogenaseIBA
01/2014
1Verapamil (Calan)FDA LinkGeneric
09/2013
1RolipramIBA
08/2013
1sildenafil (Viagra)FDA Link
08/2013
1cilostazol (Pletal)FDA LinkGeneric
08/2013

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2013